Package 63304-017-60

{"route": ["ORAL"], "spl_id": "9d320810-99dc-4276-ab06-688b60cc957d", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "unii": ["A6IEZ5M406"], "rxcui": ["616749", "728231"], "spl_set_id": ["c5848232-b7fd-4fe5-a543-16d6c4b5c0b1"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-017-05)", "package_ndc": "63304-017-05", "marketing_start_date": "20190528"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-017-28)", "package_ndc": "63304-017-28", "marketing_start_date": "20190528"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-017-60)", "package_ndc": "63304-017-60", "marketing_start_date": "20190528"}], "brand_name": "Ranolazine", "product_id": "63304-017_9d320810-99dc-4276-ab06-688b60cc957d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "63304-017", "generic_name": "Ranolazine", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranolazine", "active_ingredients": [{"name": "RANOLAZINE", "strength": "500 mg/1"}], "application_number": "ANDA211707", "marketing_category": "ANDA", "marketing_start_date": "20190528", "listing_expiration_date": "20261231"}